383 related articles for article (PubMed ID: 15827045)
21. Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis.
Oen K
Best Pract Res Clin Rheumatol; 2002 Jul; 16(3):347-60. PubMed ID: 12387804
[TBL] [Abstract][Full Text] [Related]
22. Outcome and predictive factors in juvenile rheumatoid arthritis and juvenile spondyloarthropathy.
Flatø B; Aasland A; Vinje O; Førre O
J Rheumatol; 1998 Feb; 25(2):366-75. PubMed ID: 9489836
[TBL] [Abstract][Full Text] [Related]
23. Juvenile psoriatic arthritis: longterm outcome and differentiation from other subtypes of juvenile idiopathic arthritis.
Flatø B; Lien G; Smerdel-Ramoya A; Vinje O
J Rheumatol; 2009 Mar; 36(3):642-50. PubMed ID: 19208605
[TBL] [Abstract][Full Text] [Related]
24. Persistent elevation of fibrin D-dimer predicts longterm outcome in systemic juvenile idiopathic arthritis.
Bloom BJ; Alario AJ; Miller LC
J Rheumatol; 2009 Feb; 36(2):422-6. PubMed ID: 19040298
[TBL] [Abstract][Full Text] [Related]
25. A follow-up study of juvenile rheumatoid arthritis into adulthood.
Narayanan K; Rajendran CP; Porkodi R; Shanmuganandan K
J Assoc Physicians India; 2002 Aug; 50():1039-41. PubMed ID: 12421027
[TBL] [Abstract][Full Text] [Related]
26. Achievement of a state of inactive disease at least once in the first 5 years predicts better outcome of patients with polyarticular juvenile idiopathic arthritis.
Magnani A; Pistorio A; Magni-Manzoni S; Falcone A; Lombardini G; Bandeira M; Rossi F; Sala I; Martini A; Ravelli A
J Rheumatol; 2009 Mar; 36(3):628-34. PubMed ID: 19208600
[TBL] [Abstract][Full Text] [Related]
27. Patterns of clinical remission in select categories of juvenile idiopathic arthritis.
Wallace CA; Huang B; Bandeira M; Ravelli A; Giannini EH
Arthritis Rheum; 2005 Nov; 52(11):3554-62. PubMed ID: 16255044
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and outcome of juvenile idiopathic arthritis-associated uveitis and relation to articular disease.
Grassi A; Corona F; Casellato A; Carnelli V; Bardare M
J Rheumatol; 2007 May; 34(5):1139-45. PubMed ID: 17343317
[TBL] [Abstract][Full Text] [Related]
29. Preliminary validation of clinical remission criteria using the OMERACT filter for select categories of juvenile idiopathic arthritis.
Wallace CA; Ravelli A; Huang B; Giannini EH
J Rheumatol; 2006 Apr; 33(4):789-95. PubMed ID: 16482643
[TBL] [Abstract][Full Text] [Related]
30. [Assessment of the ocular changes in children with juvenile idiopathic arthritis].
Lipiec E; Grałek M; Niwald A
Klin Oczna; 2006; 108(10-12):416-9. PubMed ID: 17455717
[TBL] [Abstract][Full Text] [Related]
31. Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features.
Singh-Grewal D; Schneider R; Bayer N; Feldman BM
Arthritis Rheum; 2006 May; 54(5):1595-601. PubMed ID: 16645998
[TBL] [Abstract][Full Text] [Related]
32. Health-related quality of life, physical function, fatigue, and disease activity in children with established polyarticular juvenile idiopathic arthritis.
Ringold S; Wallace CA; Rivara FP
J Rheumatol; 2009 Jun; 36(6):1330-6. PubMed ID: 19411394
[TBL] [Abstract][Full Text] [Related]
33. Developing outcome measures for paediatric rheumatic diseases.
Brunner HI; Ravelli A
Best Pract Res Clin Rheumatol; 2009 Oct; 23(5):609-24. PubMed ID: 19853827
[TBL] [Abstract][Full Text] [Related]
34. A prospective population based study on outcome of juvenile chronic arthritis in Costa Rica.
Arguedas O; Fasth A; Andersson-Gäre B
J Rheumatol; 2002 Jan; 29(1):174-83. PubMed ID: 11824957
[TBL] [Abstract][Full Text] [Related]
35. Delay in access to appropriate care for children presenting with musculoskeletal symptoms and ultimately diagnosed with juvenile idiopathic arthritis.
Foster HE; Eltringham MS; Kay LJ; Friswell M; Abinun M; Myers A
Arthritis Rheum; 2007 Aug; 57(6):921-7. PubMed ID: 17665486
[TBL] [Abstract][Full Text] [Related]
36. Is complementary and alternative healthcare use associated with better outcomes in children with juvenile idiopathic arthritis?
Toupin-April K; Feldman DE; Zunzunegui MV; Descarreaux M; Malleson P; Duffy CM
J Rheumatol; 2009 Oct; 36(10):2302-7. PubMed ID: 19723898
[TBL] [Abstract][Full Text] [Related]
37. Remission, minimal disease activity, and acceptable symptom state in juvenile idiopathic arthritis: defining criteria based on the juvenile arthritis disease activity score.
Consolaro A; Bracciolini G; Ruperto N; Pistorio A; Magni-Manzoni S; Malattia C; Pederzoli S; Davì S; Martini A; Ravelli A;
Arthritis Rheum; 2012 Jul; 64(7):2366-74. PubMed ID: 22231288
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of idiopathic juvenile arthritis with intraarticular triamcinolone acetonide injections].
García-Consuegra Molina J ; Merino Muñoz R
An Esp Pediatr; 2000 Oct; 53(4):314-7. PubMed ID: 11083979
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the ILAR criteria for juvenile idiopathic arthritis.
Krumrey-Langkammerer M; Häfner R
J Rheumatol; 2001 Nov; 28(11):2544-7. PubMed ID: 11708431
[TBL] [Abstract][Full Text] [Related]
40. What does "active disease" mean? patient and parent perceptions of disease activity in the systemic arthritis form of juvenile idiopathic arthritis (SO-JIA).
Batthish M; Schneider R; Ramanan AV; Achonu C; Young NL; Feldman BM
Rheumatology (Oxford); 2005 Jun; 44(6):796-9. PubMed ID: 15784631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
